Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG7H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,136
Award facts
- Contract value 100% obligated
- $10,135.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,135.96 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitive, firm fixed-price delivery order was placed without a set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal healthcare operations, specifically addressing medication supply needs for military and defense healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2031), which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies globally to military treatment facilities and other federal healthcare institutions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence through the DLA supply chain, routinely fulfilling competitive delivery orders across multiple therapeutic domains including diabetes medications, neurological treatments, and specialty pharmaceuticals to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJG7H?
SPE2DR26FJG7H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FJG7H worth?
The government has obligated $10,136 on SPE2DR26FJG7H.
Is contract SPE2DR26FJG7H an order under another contract?
Yes. SPE2DR26FJG7H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG7H competed?
The extent of competition for SPE2DR26FJG7H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award